Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Dec 15;344(Pt 3):723–730.

Purification and characterization of heparan sulphate proteoglycan from bovine brain.

Y Park 1, G Yu 1, N S Gunay 1, R J Linhardt 1
PMCID: PMC1220693  PMID: 10585858

Abstract

A heparan sulphate proteoglycan was purified from adult bovine brain tissues and its structure was characterized. The major heparan sulphate proteoglycan from whole bovine brain had a molecular mass of >200 kDa on denaturing SDS/PAGE and a core protein size of 66 kDa following the removal of glycosaminoglycan chains. Fractionation on DEAE-Sephacel showed that this proteoglycan consisted of three major forms having high, intermediate and low overall charge. All core proteins were identical in size and reacted with heparan sulphate proteoglycan-stub antibody and an antibody made to a synthetic peptide based on rat glypican. The three forms of proteoglycans had identical peptide maps and their amino acid compositional analysis did not match any of the known glypicans. The internal sequence of a major peptide showed only 37.5% sequence similarity with human glypican 5. The glycosaminoglycan chain sizes of the three forms of this proteoglycan, determined after beta-elimination by PAGE, were identical. The disaccharide compositional analysis on the heparan sulphate chains from the three forms of the proteoglycan, determined by treatment with a mixture of heparin lyases followed by high-resolution capillary electrophoresis, showed that they differed primarily by degree of sulphation. The most highly sulphated proteoglycan isolated had a disaccharide composition similar to heparan sulphate glycosaminoglycans found in brain tissue. Based on their sensitivity to low pH nitrous acid treatment, the N-sulphate groups in these proteoglycans were found to be primarily in the smaller glycosaminoglycan chains. The heparan sulphate proteoglycans were also heavily glycosylated with O-linked glycans and no glycosylphosphatidylinositol anchor could be detected.

Full Text

The Full Text of this article is available as a PDF (162.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BITTER T., MUIR H. M. A modified uronic acid carbazole reaction. Anal Biochem. 1962 Oct;4:330–334. doi: 10.1016/0003-2697(62)90095-7. [DOI] [PubMed] [Google Scholar]
  2. Baldwin M. A., Cohen F. E., Prusiner S. B. Prion protein isoforms, a convergence of biological and structural investigations. J Biol Chem. 1995 Aug 18;270(33):19197–19200. doi: 10.1074/jbc.270.33.19197. [DOI] [PubMed] [Google Scholar]
  3. Bernfield M., Kokenyesi R., Kato M., Hinkes M. T., Spring J., Gallo R. L., Lose E. J. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol. 1992;8:365–393. doi: 10.1146/annurev.cb.08.110192.002053. [DOI] [PubMed] [Google Scholar]
  4. Caldwell E. E., Nadkarni V. D., Fromm J. R., Linhardt R. J., Weiler J. M. Importance of specific amino acids in protein binding sites for heparin and heparan sulfate. Int J Biochem Cell Biol. 1996 Feb;28(2):203–216. doi: 10.1016/1357-2725(95)00123-9. [DOI] [PubMed] [Google Scholar]
  5. Carey D. J., Evans D. M., Stahl R. C., Asundi V. K., Conner K. J., Garbes P., Cizmeci-Smith G. Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan. J Cell Biol. 1992 Apr;117(1):191–201. doi: 10.1083/jcb.117.1.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chandrasekhar S., Esterman M. A., Hoffman H. A. Microdetermination of proteoglycans and glycosaminoglycans in the presence of guanidine hydrochloride. Anal Biochem. 1987 Feb 15;161(1):103–108. doi: 10.1016/0003-2697(87)90658-0. [DOI] [PubMed] [Google Scholar]
  7. Chernousov M. A., Carey D. J. N-syndecan (syndecan 3) from neonatal rat brain binds basic fibroblast growth factor. J Biol Chem. 1993 Aug 5;268(22):16810–16814. [PubMed] [Google Scholar]
  8. Choi H. U., Johnson T. L., Pal S., Tang L. H., Rosenberg L., Neame P. J. Characterization of the dermatan sulfate proteoglycans, DS-PGI and DS-PGII, from bovine articular cartilage and skin isolated by octyl-sepharose chromatography. J Biol Chem. 1989 Feb 15;264(5):2876–2884. [PubMed] [Google Scholar]
  9. David G. Integral membrane heparan sulfate proteoglycans. FASEB J. 1993 Aug;7(11):1023–1030. doi: 10.1096/fasebj.7.11.8370471. [DOI] [PubMed] [Google Scholar]
  10. David G., Lories V., Decock B., Marynen P., Cassiman J. J., Van den Berghe H. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol. 1990 Dec;111(6 Pt 2):3165–3176. doi: 10.1083/jcb.111.6.3165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dow K. E., Mirski S. E., Roder J. C., Riopelle R. J. Neuronal proteoglycans: biosynthesis and functional interaction with neurons in vitro. J Neurosci. 1988 Sep;8(9):3278–3289. doi: 10.1523/JNEUROSCI.08-09-03278.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Edens R. E., al-Hakim A., Weiler J. M., Rethwisch D. G., Fareed J., Linhardt R. J. Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives. J Pharm Sci. 1992 Aug;81(8):823–827. doi: 10.1002/jps.2600810821. [DOI] [PubMed] [Google Scholar]
  13. Faham S., Hileman R. E., Fromm J. R., Linhardt R. J., Rees D. C. Heparin structure and interactions with basic fibroblast growth factor. Science. 1996 Feb 23;271(5252):1116–1120. doi: 10.1126/science.271.5252.1116. [DOI] [PubMed] [Google Scholar]
  14. Fedarko N. S. Isolation and purification of proteoglycans. Experientia. 1993 May 15;49(5):369–383. doi: 10.1007/BF01923582. [DOI] [PubMed] [Google Scholar]
  15. Gallagher J. T., Lyon M., Steward W. P. Structure and function of heparan sulphate proteoglycans. Biochem J. 1986 Jun 1;236(2):313–325. doi: 10.1042/bj2360313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gallagher J. T., Turnbull J. E., Lyon M. Heparan sulphate proteoglycans. Biochem Soc Trans. 1990 Apr;18(2):207–209. doi: 10.1042/bst0180207. [DOI] [PubMed] [Google Scholar]
  17. Hamai A., Hashimoto N., Mochizuki H., Kato F., Makiguchi Y., Horie K., Suzuki S. Two distinct chondroitin sulfate ABC lyases. An endoeliminase yielding tetrasaccharides and an exoeliminase preferentially acting on oligosaccharides. J Biol Chem. 1997 Apr 4;272(14):9123–9130. doi: 10.1074/jbc.272.14.9123. [DOI] [PubMed] [Google Scholar]
  18. Hascall V. C., Calabro A., Midura R. J., Yanagishita M. Isolation and characterization of proteoglycans. Methods Enzymol. 1994;230:390–417. doi: 10.1016/0076-6879(94)30026-7. [DOI] [PubMed] [Google Scholar]
  19. Heinegård D. Hyaluronidase digestion and alkaline treatment of bovine tracheal cartilage proteoglycans. Isolation and characterisation of different keratan sulfate proteins. Biochim Biophys Acta. 1972 Nov 28;285(1):193–207. doi: 10.1016/0005-2795(72)90191-2. [DOI] [PubMed] [Google Scholar]
  20. Jayson G. C., Lyon M., Paraskeva C., Turnbull J. E., Deakin J. A., Gallagher J. T. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem. 1998 Jan 2;273(1):51–57. doi: 10.1074/jbc.273.1.51. [DOI] [PubMed] [Google Scholar]
  21. Karthikeyan L., Flad M., Engel M., Meyer-Puttlitz B., Margolis R. U., Margolis R. K. Immunocytochemical and in situ hybridization studies of the heparan sulfate proteoglycan, glypican, in nervous tissue. J Cell Sci. 1994 Nov;107(Pt 11):3213–3222. doi: 10.1242/jcs.107.11.3213. [DOI] [PubMed] [Google Scholar]
  22. Karthikeyan L., Maurel P., Rauch U., Margolis R. K., Margolis R. U. Cloning of a major heparan sulfate proteoglycan from brain and identification as the rat form of glypican. Biochem Biophys Res Commun. 1992 Oct 15;188(1):395–401. doi: 10.1016/0006-291x(92)92398-h. [DOI] [PubMed] [Google Scholar]
  23. Kato M., Wang H., Bernfield M., Gallagher J. T., Turnbull J. E. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. J Biol Chem. 1994 Jul 22;269(29):18881–18890. [PubMed] [Google Scholar]
  24. Kinnunen T., Raulo E., Nolo R., Maccarana M., Lindahl U., Rauvala H. Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem. 1996 Jan 26;271(4):2243–2248. doi: 10.1074/jbc.271.4.2243. [DOI] [PubMed] [Google Scholar]
  25. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  26. Lander A. D., Stipp C. S., Ivins J. K. The glypican family of heparan sulfate proteoglycans: major cell-surface proteoglycans of the developing nervous system. Perspect Dev Neurobiol. 1996;3(4):347–358. [PubMed] [Google Scholar]
  27. Liang Y., Häring M., Roughley P. J., Margolis R. K., Margolis R. U. Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J Cell Biol. 1997 Nov 17;139(4):851–864. doi: 10.1083/jcb.139.4.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lindahl B., Eriksson L., Lindahl U. Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease. Biochem J. 1995 Feb 15;306(Pt 1):177–184. doi: 10.1042/bj3060177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Litwack E. D., Stipp C. S., Kumbasar A., Lander A. D. Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system. J Neurosci. 1994 Jun;14(6):3713–3724. doi: 10.1523/JNEUROSCI.14-06-03713.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Liu J., Desai U. R., Han X. J., Toida T., Linhardt R. J. Strategy for the sequence analysis of heparin. Glycobiology. 1995 Dec;5(8):765–774. doi: 10.1093/glycob/5.8.765. [DOI] [PubMed] [Google Scholar]
  31. Lyon M., Gallagher J. T. Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver. Biochem J. 1991 Jan 15;273(Pt 2):415–422. doi: 10.1042/bj2730415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Margolis R. K., Margolis R. U. Nervous tissue proteoglycans. Experientia. 1993 May 15;49(5):429–446. doi: 10.1007/BF01923587. [DOI] [PubMed] [Google Scholar]
  33. Park Y., Cho S., Linhardt R. J. Exploration of the action pattern of Streptomyces hyaluronate lyase using high-resolution capillary electrophoresis. Biochim Biophys Acta. 1997 Feb 8;1337(2):217–226. doi: 10.1016/s0167-4838(96)00167-7. [DOI] [PubMed] [Google Scholar]
  34. Patterson W. J., Dealler S. Bovine spongiform encephalopathy and the public health. J Public Health Med. 1995 Sep;17(3):261–268. [PubMed] [Google Scholar]
  35. Pervin A., Gallo C., Jandik K. A., Han X. J., Linhardt R. J. Preparation and structural characterization of large heparin-derived oligosaccharides. Glycobiology. 1995 Feb;5(1):83–95. doi: 10.1093/glycob/5.1.83. [DOI] [PubMed] [Google Scholar]
  36. Pervin A., al-Hakim A., Linhardt R. J. Separation of glycosaminoglycan-derived oligosaccharides by capillary electrophoresis using reverse polarity. Anal Biochem. 1994 Aug 15;221(1):182–188. doi: 10.1006/abio.1994.1395. [DOI] [PubMed] [Google Scholar]
  37. Ripellino J. A., Margolis R. U. Structural properties of the heparan sulfate proteoglycans of brain. J Neurochem. 1989 Mar;52(3):807–812. doi: 10.1111/j.1471-4159.1989.tb02525.x. [DOI] [PubMed] [Google Scholar]
  38. Ripellino J. A., Margolis R. U. Structural properties of the heparan sulfate proteoglycans of brain. J Neurochem. 1989 Mar;52(3):807–812. doi: 10.1111/j.1471-4159.1989.tb02525.x. [DOI] [PubMed] [Google Scholar]
  39. Rosenberg R. D., Bauer K. A., Marcum J. A. Protease inhibitors of human plasma. Antithrombin-III. "The heparin-antithrombin system". J Med. 1985;16(1-3):351–416. [PubMed] [Google Scholar]
  40. Rosenberg R. D., Shworak N. W., Liu J., Schwartz J. J., Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest. 1997 Dec 1;100(11 Suppl):S67–S75. [PubMed] [Google Scholar]
  41. Salmivirta M., Jalkanen M. Syndecan family of cell surface proteoglycans: developmentally regulated receptors for extracellular effector molecules. Experientia. 1995 Sep 29;51(9-10):863–872. doi: 10.1007/BF01921737. [DOI] [PubMed] [Google Scholar]
  42. Shively J. E., Conrad H. E. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry. 1976 Sep 7;15(18):3932–3942. doi: 10.1021/bi00663a005. [DOI] [PubMed] [Google Scholar]
  43. Small D. H., Mok S. S., Williamson T. G., Nurcombe V. Role of proteoglycans in neural development, regeneration, and the aging brain. J Neurochem. 1996 Sep;67(3):889–899. doi: 10.1046/j.1471-4159.1996.67030889.x. [DOI] [PubMed] [Google Scholar]
  44. Snow A. D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., Wight T. N. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol. 1988 Dec;133(3):456–463. [PMC free article] [PubMed] [Google Scholar]
  45. Snow A. D., Wight T. N., Nochlin D., Koike Y., Kimata K., DeArmond S. J., Prusiner S. B. Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab Invest. 1990 Nov;63(5):601–611. [PubMed] [Google Scholar]
  46. Steinfeld R., Van Den Berghe H., David G. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol. 1996 Apr;133(2):405–416. doi: 10.1083/jcb.133.2.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Stipp C. S., Litwack E. D., Lander A. D. Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation. J Cell Biol. 1994 Jan;124(1-2):149–160. doi: 10.1083/jcb.124.1.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tekotte H., Engel M., Margolis R. U., Margolis R. K. Disaccharide composition of heparan sulfates: brain, nervous tissue storage organelles, kidney, and lung. J Neurochem. 1994 Mar;62(3):1126–1130. doi: 10.1046/j.1471-4159.1994.62031126.x. [DOI] [PubMed] [Google Scholar]
  49. Toida T., Yoshida H., Toyoda H., Koshiishi I., Imanari T., Hileman R. E., Fromm J. R., Linhardt R. J. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem J. 1997 Mar 1;322(Pt 2):499–506. doi: 10.1042/bj3220499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Watanabe K., Yamada H., Yamaguchi Y. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J Cell Biol. 1995 Sep;130(5):1207–1218. doi: 10.1083/jcb.130.5.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Williamson T. G., Mok S. S., Henry A., Cappai R., Lander A. D., Nurcombe V., Beyreuther K., Masters C. L., Small D. H. Secreted glypican binds to the amyloid precursor protein of Alzheimer's disease (APP) and inhibits APP-induced neurite outgrowth. J Biol Chem. 1996 Dec 6;271(49):31215–31221. doi: 10.1074/jbc.271.49.31215. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES